BioCentury

8:00 AM GMT, Dec 20, 2010
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical Results

Pomalidomide: Phase II data

A Phase II trial in 70 patients with MM refractory to both Revlimid lenalidomide and Velcade bortezomib showed that

Read the full 198 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.